Kerecis is a developer of patent-pending MariGen(TM), an omega3 fish-skin acellular dermal matrix transplantation technology. read more

EMPLOYEE PARTICIPANTS: 23

TOTAL RATINGS: 257

CEO: Gudmundur Sigurjonsson

Kerecis CEO & Leadership Team Ratings

Gudmundur Sigurjonsson and the Kerecis leadership team are scored a F by 21 employees placing it in the Bottom 5% of companies sized 11-50 Employees. The Leadership score includes details about how employees evaluate their executive team, CEO and manager.

Based on 51 ratings, the Leadership score of 28/100 combines employee feedback on their CEO (30/100), Manager (35/100), and Executive Team (25/100).

Gudmundur Sigurjonsson Kerecis CEO Rating

Bottom 5% Compared to other companies of similar size

30 / 100

Gudmundur Sigurjonsson the CEO of Kerecis received an average score of 30 from Kerecis employees.

Kerecis Manager Rating

Bottom 5% Compared to other companies of similar size

35 / 100

Managers received an average score of 35 from Kerecis employees.

Kerecis Executive Team Rating

Bottom 5% Compared to other companies of similar size

25 / 100

The Executive team received an average score of 25 from Kerecis employees.

Rate your company